Advanced search
Start date
Betweenand
Related content

(EN) USE OF CYANOGLUCOSIDES AND PHARMACEUTICAL FORMULATIONS THEREOF IN THE TREATMENT OF DIABETES

OfficeWIPO
Document type:Patent
Inventor(s): Luiz Leonardo Saldanha; Anne Lígia Dokkedal Bosqueiro; José Roberto Bosqueiro; Nathalia Aparecida De Paula Camaforte Henriques; Priscilla Maria Ponce Vareda; Wagner Vilegas; Emerson Ferreira Queiroz; Laurence Marcourt; Jean Wolfender-Luc
Applicant:Universidade Estadual Paulista Júlio de Mesquita Filho (Unesp); Université de Genève
Year: 2016
Application Number:PCT/BR2016/050148
IPC: A61K 31/275 A61K 31/7028 A61P 3/00 A61P 3/10
Abstract

The present Invention relates to the use of cyanoglucoside according to formula (I) and formulations thereof in the prevention and/or treatment of diabetes and/or metabolic syndrome; wherein R1, R2 and R3 are independently selected from an optionally substituted mono- or di- saccharide, -O-R4, -O- C(O)-R4 and halogen such as CI, F or Br, wherein R4 is selected from H, alkyl such as methyl, as well as tautomers, geometrical isomers, optically active forms, pharmaceutically acceptable salts and pharmaceutically active derivative thereof.


FAPESP's process: 09/52237-9 - Standardized herbal medicines for the treatment of chronic diseases
Grantee:Wagner Vilegas
Principal Investigator:Wagner Vilegas
Institution: Universidade Estadual Paulista (UNESP). Campus Experimental do Litoral Paulista. Instituto de Biociências (IB-CLP)
Support Opportunities: BIOTA-FAPESP Program - Thematic Grants